The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response
Authors:
- 1 November 2011
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 132 (2-3) , 121-124
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Neurexin-1 and Frontal Lobe White Matter: An Overlapping Intermediate Phenotype for Schizophrenia and Autism Spectrum DisordersPLOS ONE, 2011
- Rare NRXN1 promoter variants in patients with schizophreniaNeuroscience Letters, 2010
- LRRTM2 Interacts with Neurexin1 and Regulates Excitatory Synapse FormationNeuron, 2009
- Mouse neurexin-1α deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairmentsProceedings of the National Academy of Sciences, 2009
- Neuroligins and neurexins link synaptic function to cognitive diseaseNature, 2008
- Likelihood-Based Association Analysis for Nuclear Families and Unrelated Subjects with Missing Genotype DataHuman Heredity, 2008
- Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophreniaFrontiers in Molecular Neuroscience, 2008
- Pharmacological treatment of primary negative symptoms in schizophrenia: A systematic reviewSchizophrenia Research, 2006
- Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis in rat hippocampal neuronsMolecular and Cellular Neuroscience, 2006
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004